News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amphastar Pharmaceuticals, Inc. (AMPH) Announces Exercise of Over-Allotment Option



6/30/2014 8:08:09 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RANCHO CUCAMONGA, Calif., June 30, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Amphastar) (Nasdaq:AMPH), a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable and inhalation products, today announced that the underwriters of its initial public offering exercised in full their option to purchase from Amphastar 1,200,000 additional shares of its common stock at the initial public offering price of $7.00 per share.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES